Genelabs, GlaxoSmithKline deal

GSK will acquire Genelabs in a tender offer of $1.30 per share, for a total of $56.8 million in cash. The price is a 465% premium to Genelabs' close of $0.23 on Oct. 29, the day before the deal was announced. Genelabs' board recommended that stockholders tender their shares. ...